| Thu, 09 Sep 2010 11:30:00 GMT |
| Rigel to Present at Stifel Nicolaus Healthcare Conference |
|
[PR Newswire] - Rigel Pharmaceuticals, Inc. today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Stifel Nicolaus Healthcare Conference in Boston, MA on Thursday, September 16th at 9:45a.m. |
| Fri, 06 Aug 2010 17:04:21 GMT |
| RIGEL PHARMACEUTICALS INC Financials |
|
|
| Wed, 04 Aug 2010 15:51:00 GMT |
| Industry Analyst At RBC Capital Markets Reveals 5 Factors When Evaluating Biotech Companies |
|
[Wall Street Transcript] - 67 WALL STREET, New York - August 4, 2010 - The Wall Street Transcript has recently published its Biotechnology & Pharmaceuticals Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs, Equity Analysts and Money Managers. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online. |
| Tue, 03 Aug 2010 16:58:48 GMT |
| RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
|
|
| Tue, 03 Aug 2010 13:09:59 GMT |
| Rigel posts 2Q net income on AstraZeneca payment |
|
[AP] - Rigel Pharmaceuticals Inc. on Tuesday reported a second-quarter profit after it received a hefty payment from development partner AstraZeneca. |